MRTNZ

MRTNZ Investment Office · S&P 500 · The 360 Vantage

MMM · NYSE

3M Company

Health Care · Medical/Dental Instruments

Reference price$182.48As of Jul 28, 2026
Market capitalization$94.11B
52-week range$139.34$179.29
S&P 500 portfolio weight0.15%
Data qualitycomplete

Street view

Analyst targets

Published sell-side aggregation—not an MRTNZ forecast.

Low$132.00-27.7% vs. reference
Average$180.62-1.0% vs. reference
High$218.00+19.5% vs. reference
7 Buy4 Hold2 Sell

Forward calendar

Current earnings expectations

Consensus may change until the company reports.

Expected reportNot availableSep 2026
Consensus EPS$2.364 estimates
Expected range$2.35–$2.37Low to high EPS
Dec 2026$8.91Street EPS consensus
Dec 2027$9.52Street EPS consensus
Dec 2028$9.95Street EPS consensus

Reported results

Annual financial snapshot

Fiscal period ended Dec 31, 2025.

MetricCurrentPrior
Revenue+1.5% YoY$24.95B$24.58B
Operating income$4.63B$4.82B
Net income$3.25B$4.17B
Operating cash flow$2.31B$1.82B
Capital expenditures($0.91B)($1.18B)

Current context

Related news

Company-linked articles surfaced by Nasdaq.

Evidence

Sources & method

Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.